Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecopipam Treatment of Tourette Syndrome
NCT01244633Phase 2Completed
- Sponsor
- Emalex Biosciences
- Start
- Oct 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ecopipam in Tourette syndrome (TS), sponsored by Emalex Biosciences. Started Oct 2010; status: completed.
02
Drugs
ecopipam
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01244633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244633.